Quick Answer
Edesa Biotech, Inc. reported Shares Outstanding of 7.14 million shares for fiscal year 2025.
Edesa Biotech, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 7.14M | +119.9% |
| 2024 | 3.25M | +5.6% |
| 2023 | 3.08M | +29.2% |
| 2022 | 2.38M | -82.1% |
| 2021 | 13.30M | +38.3% |
| 2020 | 9.62M | +28.1% |
| 2019 | 7.50M | +40.8% |
| 2018 | 5.33M | +254.7% |
| 2017 | 1.50M | -85.2% |
| 2016 | 10.14M | +26.9% |
| 2015 | 7.98M | +0.5% |
| 2014 | 7.94M | +1.5% |
| 2014 | 7.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 8.33M | +140.3% | +16.7% |
| September 30, 2025 | 7.14M | +119.9% | +1.7% |
| June 30, 2025 | 7.02M | +116.3% | +0.0% |
| March 31, 2025 | 7.02M | +118.4% | +102.5% |
| December 31, 2024 | 3.47M | +9.6% | +6.8% |
| September 30, 2024 | 3.25M | +5.6% | +0.0% |
| June 30, 2024 | 3.25M | -84.4% | +1.0% |
| March 31, 2024 | 3.22M | -84.0% | +1.6% |
- Edesa Biotech, Inc. showed an increase of +119.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Edesa Biotech, Inc.’s shares outstanding has declined by 8.8% (from 7.83 million shares to 7.14 million shares).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: